Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

The Pharmacogenomics Journal (2)
British Journal of Cancer (1)
Nature Genetics (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (4)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Diseases
Drug discovery
Genetics
Health care
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: F Aminkeng Clear advanced filters

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

A genome-wide study identifies common variation near IRF6 associated with liver injury induced by IFN-β in individuals treated for multiple sclerosis. The risk locus is associated with differential expression of IRF6 and may help guide safer use of this biologic.

Kaarina Kowalec
Galen E. B. Wright
Bruce C. Carleton
Research16 Jul 2018
Nature Genetics

Volume: 50, P: 1081-1085
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent

F Aminkeng
C J D Ross
M R Hayden
Research16 Apr 2013
The Pharmacogenomics Journal

Volume: 14, P: 160-170
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

A Ruzzo
F Graziano
M Magnani
ResearchOpen Access24 Aug 2017
British Journal of Cancer

Volume: 117, P: 1269-1277
Pharmacogenomic diversity in Singaporean populations and Europeans

L R Brunham
S L Chan
Y Y Teo
ResearchOpen Access27 May 2014
The Pharmacogenomics Journal

Volume: 14, P: 555-563